Articles Referencing SIGA
Strong Quarter for Merck KGaA - Analyst Blog
3/8/2013, 9:40 am from Zacks.com in Investing, Business, Stocks
Merck KGaA ( MKGAF ) reported
fourth quarter 2012 earnings per American Depository Receipt (ADR)
of $2.66, up 18.8% year over year.
Revenues for the reported quarter were up 8% year over... Read >>
Positive Results on UCB's Vimpat - Analyst Blog
3/6/2013, 4:55 pm from Zacks.com in Investing, Business, Stocks
UCB ( UCBJF ) recently
received good news with the company announcing positive results on
Vimpat (lacosamide) from a phase III study being conducted to
support the label expansion of the... Read >>
UCB In-licenses Parkinson's Drug - Analyst Blog
3/1/2013, 4:00 pm from Zacks.com in Investing, Business, Stocks
UCB ( UCBJF )
recently announced that it has licensed exclusive global rights to
tozadenant (SYN115) for Parkinson's disease from Biotie
Therapies. The Candidate
Tozadenant is an orally... Read >>
UCB Beats on Revs - Analyst Blog
2/28/2013, 11:28 am from Zacks.com in Investing, Business, Stocks
UCB ( UCBJF ) reported 2012
earnings per share of $2.80, up 12% on a reported basis but down 4%
at constant exchange rates (CER).
Revenues for the year 2012 were approximately $4,450.7... Read >>
Mylan Beats by a Penny, Guides Up - Analyst Blog
2/28/2013, 8:40 am from Zacks.com in Investing, Business, Stocks
Mylan, Inc. 's ( MYL ) fourth-quarter
2012 earnings (excluding special items) of 65 cents per share beat
the Zacks Consensus Estimate by a penny. The earnings beat was
primarily... Read >>
Ariad Reports in line 4Q Loss - Analyst Blog
2/27/2013, 10:10 am from Zacks.com in Investing, Business, Stocks
Ariad Pharmaceuticals, Inc. ( ARIA ) reported fourth
quarter loss of 36 cents per share, compared with the year-ago loss
of 23 cents per share. The Zacks Consensus Estimate for the... Read >>
Questcor Beats Overall - Analyst Blog
2/27/2013, 10:00 am from Zacks.com in Investing, Business, Stocks
Questcor Pharmaceuticals Inc. ( QCOR ) reported fourth
quarter 2012 adjusted earnings per share of $1.09, up 132% from the
year-ago period. Earnings surpassed the Zacks Consensus Estimate... Read >>
Label Expansion for Astellas - Analyst Blog
2/25/2013, 4:15 pm from Zacks.com in Investing, Business, Stocks
Astellas Pharmaceuticals Inc. ( ALPMY ) and Kyowa
Hakko Kirin Co., Ltd. recently announced the receipt of Japan's
Ministry of Health, Labour and Welfare (MHLW) approval for the
drugs,... Read >>
NPS Pharma Incurs Wider 4Q Loss - Analyst Blog
2/25/2013, 10:00 am from Zacks.com in Investing, Business, Stocks
NPS Pharmaceuticals, Inc. ( NPSP ) reported fourth
quarter 2012 net loss per share of 14 cents, wider than the Zacks
Consensus Estimate of a loss of 9 cents and the year-ago loss of... Read >>
UCB - ConfometRx Collaborate - Analyst Blog
2/21/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks
UCB ( UCBJF ) recently
entered into an agreement with ConfometRx for the discovery of
novel medicines in the neuroscience therapeutic area. This research
and development (R&D)... Read >>
A Judge's Ruling Could Send these Stocks Soaring Very Soon
6/20/2011, 11:00 am from David Sterman in Investing, Investing Ideas
There's a drama unfolding in the health care field that is as
dramatic as the daytime soap operas. Lots of "he said, she said"
has been tossed around, and just to add a little spice, a... Read >>
I've Found a Handful of Companies That Could Grow 200% -- or More -- by 2012
3/4/2011, 9:00 am from David Sterman in Investing, Investing Ideas
Early-stage companies spend many years planning for the day when
everything clicks. For a number of them, 2012 could be the year
when all their hard work pays off. So I decided to look... Read >>
5 Top Stocks Under $5
2/21/2011, 12:00 pm from David Sterman in Investing, Investing Ideas
I'm a big fan of low-priced stocks -- especially those that are
under $5 a share. At that level, mostmutual fund managers are
restricted from owning them. But if growth plans pan out... Read >>
Squeeze ideas: Highly Shorted Stocks With Improving Analyst Sentiment
11/19/2010, 4:28 pm from Kapitall in Investing, Investing Ideas, Stocks
Compiled by Luis Gonzalez : The following is a list of stocks with high short float. Short-sellers seem to think there's more downside to these names, but Wall Street analysts disagree. All of... Read >>
3 Insider Stocks That Could Pop
11/10/2010, 8:00 am from David Sterman in Investing, Basics, Investing Ideas
As
earnings season
winds down, insider activity heats up. That's because insiders
(classified as company executives, directors and beneficial owners)
get the green light to buy or sell their... Read >>